News

The nation’s top spy has asked for help from Australian individuals, businesses and organisations on cybersecurity, saying ...
AT about noon on July 18, more than 200 Immigration autogates nationwide suddenly went offline for foreigners, causing chaos ...
Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission ...
The BYD Shark 6, the first plug-in hybrid electric ute to hit Australia's shores, is leading the charge of plug-in hybrid electric utes, followed closely by PHEV versions of the Ford Ranger and GWM ...
We ride the 2025 Stark Vark EX! The European-based manufacturer has released its latest electric dual-sport motorcycle. Check ...
Hyundai’s 2026 Palisade adds its first hybrid powertrain, enhanced safety tech and a new off-road-ready XRT PRO ...
Sunsave offers a subscription-based rooftop solar service designed to address barrier in the UK energy market: high upfront ...
Caranx Medical, a French medical device company specializing in the development of an autonomous robot to democratize access to Transcatheter Aortic Valve Implantation, a lifesaving procedure, has ...
Tempus AI (TEM) has recently secured FDA clearance for its Tempus ECG-Low EF software, an innovative AI-driven product aiding cardiovascular assessments. This development aligns with TEM’s aim ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.
FDA grants 510 (k) clearance for Tempus AI’s ejection fraction software The Tempus ECG-Low EF model is trained on data from over 930,000 ECGs and more than 170,000 individuals.